Cargando…
Vaccine‐induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine–A case report
Vaccination with ChAdOx1 nCov‐19 can result in vaccine‐induced immune thrombotic thrombocytopenia (VITT). This phenomenon mimics heparin‐induced thrombocytopenia (HIT), yet it does not require heparin as a trigger. HIT screen/ELISA along with optical density and functional assay are useful in diagno...
Autores principales: | Al Rawahi, Bader, BaTaher, Hashem, Jaffer, Zoheb, Al‐Balushi, Aya, Al‐Mazrouqi, Asma, Al‐Balushi, Noof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385181/ https://www.ncbi.nlm.nih.gov/pubmed/34466769 http://dx.doi.org/10.1002/rth2.12578 |
Ejemplares similares
-
Acute Arterial Occlusion Following ChAdOx1 nCov-19 (Oxford–AstraZeneca) Vaccination
por: Ali, Azhar, et al.
Publicado: (2022) -
Stevens-Johnson Syndrome Following ChAdOx1 nCoV-19 Vaccination (AstraZeneca)
por: Lee, Hyo Jin, et al.
Publicado: (2023) -
Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination
por: Robichaud, Julie, et al.
Publicado: (2021) -
Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine
por: Clayton-Chubb, Daniel, et al.
Publicado: (2021) -
Bilateral adrenal haemorrhage with renal infarction after ChAdOx1 nCoV-19 AstraZeneca vaccination
por: Tha, Tun, et al.
Publicado: (2022)